These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 21856747

  • 1. Ligand-dependent corepressor acts as a novel androgen receptor corepressor, inhibits prostate cancer growth, and is functionally inactivated by the Src protein kinase.
    Asim M, Hafeez BB, Siddiqui IA, Gerlach C, Patz M, Mukhtar H, Baniahmad A.
    J Biol Chem; 2011 Oct 28; 286(43):37108-17. PubMed ID: 21856747
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M, Asim M, Eskelinen H, Linke T, Baniahmad A.
    J Mol Endocrinol; 2009 May 28; 42(5):429-35. PubMed ID: 19223455
    [Abstract] [Full Text] [Related]

  • 3. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
    Esmaeili M, Jennek S, Ludwig S, Klitzsch A, Kraft F, Melle C, Baniahmad A.
    J Mol Cell Biol; 2016 Jun 28; 8(3):207-20. PubMed ID: 26993046
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth.
    Daniels G, Li Y, Gellert LL, Zhou A, Melamed J, Wu X, Zhang X, Zhang D, Meruelo D, Logan SK, Basch R, Lee P.
    Endocr Relat Cancer; 2014 Feb 28; 21(1):127-42. PubMed ID: 24243687
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Krüppel-like factor 8 is a novel androgen receptor co-activator in human prostate cancer.
    He HJ, Gu XF, Xu WH, Yang DJ, Wang XM, Su Y.
    Acta Pharmacol Sin; 2013 Feb 28; 34(2):282-8. PubMed ID: 23023312
    [Abstract] [Full Text] [Related]

  • 12. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
    Yoon HG, Wong J.
    Mol Endocrinol; 2006 May 28; 20(5):1048-60. PubMed ID: 16373395
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Androgen receptor regulates SRC expression through microRNA-203.
    Siu MK, Chen WY, Tsai HY, Yeh HL, Yin JJ, Liu SY, Liu YN.
    Oncotarget; 2016 May 03; 7(18):25726-41. PubMed ID: 27028864
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.
    Schmidt LJ, Duncan K, Yadav N, Regan KM, Verone AR, Lohse CM, Pop EA, Attwood K, Wilding G, Mohler JL, Sebo TJ, Tindall DJ, Heemers HV.
    Mol Endocrinol; 2012 May 03; 26(5):716-35. PubMed ID: 22456196
    [Abstract] [Full Text] [Related]

  • 19. A designed cell-permeable aptamer-based corepressor peptide is highly specific for the androgen receptor and inhibits prostate cancer cell growth in a vector-free mode.
    Reeb CA, Gerlach C, Heinssmann M, Prade I, Ceraline J, Roediger J, Roell D, Baniahmad A.
    Endocrinology; 2011 Jun 03; 152(6):2174-83. PubMed ID: 21486935
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.